Abbott Laboratories

NYSE: ABT
$100.68
-$0.39 (-0.4%)
Closing price September 23, 2022
With the potential for a serious downside move looming, and interest rates definitely headed higher, investors may want to consider the Dividend Aristocrats. These seven are in defensive sectors and...
After markets close Tuesday, video streaming giant Netflix will report quarterly earnings that are not expected to be a significant improvement over prior quarter results. Four other firms report...
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Azul, Boeing, Boston Scientific, Callon Petroleum, Corning, Datadog, Etsy, HCA Healthcare, Kohl's, Medtronic, Merck,...
In a market that is very volatile, and that could be headed much lower if we are already in a recession, these seven safe-haven stocks make a ton of sense now. With even moderate appreciation in the...
Here is what to expect when three leading companies in different sectors report quarterly results before markets open on Wednesday.
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Antero Midstream, C3.ai, Equitrans Midstream, Hewlett Packard Enterprise, iQIYI, Johnson & Johnson, Opendoor Technologies,...
Wednesday afternoon's top analyst upgrades and downgrades included Abbott Laboratories, Camping World, Chevron, Endo International, Marathon Oil, Meta Platforms and Opendoor Technologies.
Given Warren Buffet's proclivity for only owning stock of companies that he understands inside and out, these 10 top health care picks with big, dependable dividends make sense now for growth and...
These five stocks are on the Dividend Aristocrats list, are in defensive sectors and look poised to do well the rest of 2022. They are Buy rated at top Wall Street firms as well. With interest rates...
Friday's top analyst upgrades and downgrades included Abbott Laboratories, ArcelorMittal, AT&T, Chewy, Clean Energy Fuels, Fisker, Freeport-McMoRan, Intel, Las Vegas Sands, Lennar, Marathon Digital,...
Here is a preview of four earnings reports due out before markets open on Wednesday.
Thursday's top analyst upgrades and downgrades included AT&T, Abbott Laboratories, Advanced Micro Devices, Affirm, Canopy Growth, Cleanspark, Eli Lilly, ESS Tech, Global Payments and Luminar...
Friday afternoon's top analyst upgrades and downgrades included Bank of America, Chewy, Costco, Lululemon, Oracle, Peloton, Roku and more.
Broadcom, Pfizer and these other top companies are expected to lift the dividends they pay to shareholders, and their stocks are rated Buy across Wall Street, making them excellent total return...
Now is the time to reduce risk and more to safer ideas. Top-quality health care stocks may be the way to go for the rest of 2021 and in 2022, and these five Dividend Aristocrats make good sense now...